The blood-brain barrier hypothesis in drug resistant epilepsy
- PMID: 22252997
- PMCID: PMC3326249
- DOI: 10.1093/brain/awr343
The blood-brain barrier hypothesis in drug resistant epilepsy
Comment on
-
The treatment of super-refractory status epilepticus: a critical review of available therapies and a clinical treatment protocol.Brain. 2011 Oct;134(Pt 10):2802-18. doi: 10.1093/brain/awr215. Epub 2011 Sep 13. Brain. 2011. PMID: 21914716 Review.
References
-
- Beghi E, Shorvon S. Antiepileptic drugs and the immune system. Epilepsia. 2011;52:40–4. - PubMed
-
- Beilin B, Rusabrov Y, Shapira Y, Roytblat L, Greemberg L, Yardeni IZ, et al. Low-dose ketamine affects immune responses in humans during the early postoperative period. Br J Anaesth. 2007;99:522–7. - PubMed
-
- Cheyuo C, Wu RQ, Zhou MA, Jacob A, Coppa G, Wang P. Ghrelin suppresses inflammation and neuronal nitric oxide synthase in focal cerebral ischemia via the vagus nerve. Shock. 2011;35:258–65. - PubMed
-
- Heath DL, Vink R. Neuroprotective effects of MgSO4 and MgCl2 in close head injury: a comparative phosphorus NMR study. J. Neurotrauma. 1998;15:183–9. - PubMed
